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The impact of immigration on public and out-of-pocket health expenditure 
in OECD countries 
Abstract 
 This paper examined the impact of the inflow of new immigrants on public and out-of-pocket 
health expenditure in 33 Organisation for Economic Cooperation and Developments (OECD) countries 
over the period of 2000-2015. Dynamic panel data analysis is carried out using the one-step system 
‘Generalised Method of Moments’ and the instrumental variable (IV) estimation approach while 
controlling for potential endogeneity. The inflow of new immigrants is modelled as a determinant of 
health expenditure. The results are robust to both static and dynamic models. The results show that an 
increasing inflow of immigrants is significantly related to out-of-pocket, but, surprisingly, not with 
public health expenditure. Moreover, the findings are similar for countries that primarily have publicly 
funded healthcare systems or those more dominated by private financing of healthcare. It can be 
concluded that new immigrants do not seek publicly funded healthcare at least at the initial years of 
their relocation and that their arrival does not trigger a significant rise in public healthcare expenditure 
in the OECD countries. 
Key Words: Immigrants; healthcare expenditure; system GMM; instrumental variable; OECD 
countries 
JEL Classification:  C3, C33, C36, I10, I18, H40, H51 
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The impact of immigration on public and out-of-pocket health expenditure in OECD countries 
1. Introduction 
 There is no doubt that rising healthcare expenditure and rising inflows of foreign immigrants 
are two of the most contentious policy issues in many Organization for Economic Cooperation and 
Development (OECD) countries in recent times. As healthcare expenditure is predominantly funded by 
governments in these countries [1], any increase in healthcare demand imposes an additional burden on 
public budgets which applies new challenges to the healthcare system [2] and increases the burden on 
public social welfare spending [3-5]. In 2015, 7.13 million new documented immigrants entered these 
countries compared to 3.8 million in the year 2000, a rise of almost 85% [6].  
 Many empirical studies have argued that increased immigration increases public spending [7]. 
Some researchers indicated that the magnitude of the impact of rising immigration on public spending 
is moderate [4, 7], whilst others found the link burdensome [3]. Many studies argue that immigrants 
dramatically increase public spending, especially in countries where social welfare is generous [8, 9]. 
In most OECD countries, healthcare is either generously financed or subsidised by governments 
therefore, it is important to examine the influence of new immigrants on public healthcare expenditure.  
 Healthcare is a basic human right, hence, OECD countries are expected to ensure equal access 
to healthcare for all. However, the budgets of many countries are already under extreme pressure as 
total expenditure on health reached on average approximately 9% of gross domestic product (GDP) in 
2016 [6, 10]. One-third of all OECD countries spend more than 10% of their national income on 
healthcare. This has become a critical policy concern for governments [10] and a key fiscal challenge 
[11] which has prompted investigation of the key elements of rising healthcare expenditure [12]. Past 
empirical studies have identified growth in national income, improvements in technology, aging 
populations, lifestyle choices and a rising incidents of chronic diseases as the primary drivers of 
increasing healthcare expenditure [11, 13-16].  
 Some country-specific studies have investigated healthcare usage and expenditure patterns of 
recent immigrant populations and have concluded that immigrants generally consume less healthcare 
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due to inequalities in accessing publicly funded healthcare [17-20]. Some of the significant factors 
contributing to new immigrants’ lower use of healthcare services are: i) cultural differences and 
linguistic barriers [21]; ii) lack of income to afford insurance coverage [2]; iii) lack of understanding of 
the host countries healthcare system [22], and iv) unfavourable healthcare policies [17, 22]. Supporting 
these findings, some empirical studies have concluded that total healthcare consumption and 
expenditure of immigrants are either significantly lower than the host country population [20, 23, 24] 
or approximately similar [18, 25].  
 Despite these findings, many researchers indicated that there is a common sentiment among the 
host country population that immigrants are a burden on the public welfare system and should finance 
their own healthcare expenses [26, 27]. Foreseeing this trend several OECD countries have conducted 
key welfare reforms in the past decades. For instance, in 1996, the U.S. Government implemented a 
five-year prohibition on non-refugee immigrant’s eligibility to access the publicly funded Medicare 
program [20] and other OECD countries are also in the process of formulating policy changes (both 
favourable and unfavourable to immigrants) in their welfare systems, especially in the healthcare sector 
[22, 28]. Such reforms substantially influence the level of healthcare consumption by new immigrants 
and act as a barrier to equality of access to healthcare.  
 Noticeably, all previous research investigating healthcare access, use and expenditure of new 
immigrant populations were country-specific, or focused mainly on individual states of either the USA 
or Canada. Although, many of these studies advocated for equity and generous public healthcare 
funding for immigrants [17, 29, 30], it is still unclear whether the inflow of new immigrants is 
responsible for rising healthcare expenditure in OECD countries. Thus, no studies have yet examined 
the link between the increasing inflow of immigrants and healthcare expenditure for OECD countries. 
Therefore, the following research questions arise: i) does an increasing number of immigrants contribute 
to rising healthcare expenditure?; ii) is healthcare expenditure by immigrants significantly related to 
public or out-of-pocket healthcare expenditure?; and iii) does the link between increasing number of 
immigrants and health expenditure vary due to different healthcare policy and funding frameworks?   
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 Using cross-country OECD data for the period of 2000 to 2015, the main objective of this paper 
is to examine whether the increasing inflow of immigrants is a key determinant of rising health 
expenditure, particularly in predominantly publicly funded systems. This study contributes to the 
existing literature by investigating the growing sentiment that increasing inflows of immigrants imposes 
additional pressure on publicly funded healthcare. Although many scholars found the evidence of a 
‘healthy immigrant effect’ (immigrants’ are generally healthy and demand less healthcare [29, 31]), 
they have also observed a rapid deterioration of immigrants’ health in the long-term [31, 32] because 
they take riskier occupations, work longer hours and in unhealthier working conditions compared to the 
host country populations [33, 34]. This study also looked into whether new immigrants’ influence the 
rate of out-of-pocket healthcare expenditure. Rather than focusing on one country or state, this study 
used cross-country panel data while using an efficient estimation technique to account for unobserved 
heterogeneity and potential endogeneity bias in the model. Lastly, using dummy variables the study 
examined how the relationship differs due to variations in healthcare policy and language of the host 
countries.  
 The paper is organised as follows. The next section describes the data, regression model and 
methods used. Section 3 comprises the estimation results and section 4 provides a detail discussion of 
the findings. Lastly, section 5 contains a brief conclusion and discusses the policy implications that 
arise.   
2. Data and Methods 
2.1 Variable definitions and model specifications 
 This study used a heterogeneous panel data method to examine the relationship between new 
inflows of immigrants and healthcare expenditure in OECD countries covering the period of 2000 to 
2015. Data has been collected for 33 countries2 from the OECD statistical database [6]. The main 
exogenous variable in the model is the total inflow of foreign immigrants (INFR) in each country per 
 
2 Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, 
Israel, Italy, Japan, Korea Republic, Latvia, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, 
Slovenia, Spain, Sweden, Switzerland, United Kingdom and United States. 
Countries excluded due to lack of availability of data are Chile and Turkey.  
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year and two outcome variables are the log of public healthcare expenditure per capita (PUBHE) and 
the log of out-of-pocket health expenditure per capita (OOPHE) both expressed at current (USD) PPP 
prices. Table 1 shows the descriptive statistics of the variables over several periods. The mean values 
of the key variables indicate that public and out-of-pocket healthcare expenditure per capita has more 
than doubled in the past sixteen years and so has the average inflow of immigrants in OECD countries. 
The obese male and older age population have increased whilst the young population has decreased. 
Less number of deaths have occurred during the period.  
Table 1. Mean values of model variables  
 
 
       
Overall 2000 2005 2010 2015 
PUBHE+ 2177.13 1340.09 1863.33 2491.28 2935.31 
OOPHE+ 790.74 524.18 711.29 865.72 1056.40 
INFR* 165667 127687 159471 158291 217661 
GDPPC+ 33675 24477 30260 36234 42731 
OBSM 19.20 15.77 18.20 20.69 22.58 
TREDU 35.51 26.53 32.85 38.24 42.63 
PHMCN+ 466.36 308.87 422.59 532.88 556.74 
POP65 15.27 13.95 14.67 15.56 17.20 
POP14 17.69 19.06 17.93 17.17 16.90 
CANDT 217 233 220 209 201 
           Notes: + indicates variables are expressed in USD, per capita current PPP 
                    * indicates average inflow of foreign immigrants in OECD countries per year 
  
 In addition to the primary exogenous variable, some key control variables were included in the 
model replicating past empirical studies. The estimated regression model controlled for the percentage 
of the population (18+ and male) who are obese (OBSM) based on body mass index. This variable has 
been identified as a critical element of rising healthcare expenditure [16, 35]. The percentage of the 
population over 65 years old (POP65) and between 0 to 14 years old (POP14) are included, as they 
represent population age structure [36] and have a higher tendency to consume healthcare [37]. Holding 
other things constant, the longevity of the population is expected to increase with quality improvements 
of healthcare services. Per capita pharmaceutical consumption (PHMCN) was included as growth in 
drug prices is considered a key driver of rising healthcare expenditure [38, 39]. The percentage of the 
population (between 24-65 years old) with tertiary education (TREDU) was included as the level of 
education influences both health status and healthcare expenditure [40] and the probability of 
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catastrophic healthcare expenditure [41]. The number of deaths due to cancer (CAND) captures changes 
in medical technology with the assumption that improvements will significantly reduce mortality related 
to diseases such as cancer. Past studies have also used infant mortality and life expectancy [42], the 
number of medical equipment [43] and R&D spending for healthcare [15] as a proxy for technological 
progress. Finally, GDP per capita is used to proxy national income as many empirical studies have 
concluded that rising national income is the primary determinant of rising healthcare expenditure [11, 
14, 15].  
 The empirical models are specified as follows:  
PUBHE it = 𝛼 𝑃𝑈𝐵𝐻𝐸𝑖,𝑡−1 + 𝛽1𝐼𝑁𝐹𝑅𝑖𝑡 + 𝛽2 𝐺𝐷𝑃𝑃𝐶𝑖𝑡  + 𝛽3𝑃𝑂𝑃65𝑖𝑡  +𝛽4 𝑃𝐻𝑀𝐶𝑁𝑖𝑡  
 + 𝛽5 𝑃𝑂𝑃14𝑖𝑡  + 𝛽6 𝑇𝑅𝐸𝐷𝑈𝑖𝑡  +𝛽7 𝑂𝐵𝑆𝑀𝑖𝑡  + 𝛽8 𝐶𝐴𝑁𝐷𝑇𝑖𝑡   + 𝑒𝑖  +  𝑢𝑖          (1) 
OOPHE it = 𝛼𝑂𝑂𝑃𝐻𝐸𝑖,𝑡−1 + 𝛽1𝐼𝑁𝐹𝑅𝑖𝑡  + 𝛽2 𝐺𝐷𝑃𝑃𝐶𝑖𝑡  + 𝛽3𝑃𝑂𝑃65𝑖𝑡  +𝛽4 𝑃𝐻𝑀𝐶𝑁𝑖𝑡  
 + 𝛽5 𝑃𝑂𝑃14𝑖𝑡  + 𝛽6 𝑇𝑅𝐸𝐷𝑈𝑖𝑡  +𝛽7 𝑂𝐵𝑆𝑀𝑖𝑡  + 𝛽8 𝐶𝐴𝑁𝐷𝑇𝑖𝑡   + 𝑒𝑖  +  𝑢𝑖          (2) 
 Three dummy variables were added to increase validity of results and the estimated models are: 
PUBHE it = 𝛼 𝑃𝑈𝐵𝐻𝐸𝑖,𝑡−1 + 𝛽1𝐼𝑁𝐹𝑅𝑖𝑡 + 𝛽2 𝐺𝐷𝑃𝑃𝐶𝑖𝑡  + 𝛽3𝑃𝑂𝑃65𝑖𝑡  +𝛽4 𝑃𝐻𝑀𝐶𝑁𝑖𝑡   
 + 𝛽5 𝑃𝑂𝑃14𝑖𝑡  + 𝛽6 𝑇𝑅𝐸𝐷𝑈𝑖𝑡  +𝛽7 𝑂𝐵𝑆𝑀𝑖𝑡  + 𝛽8 𝐶𝐴𝑁𝐷𝑇𝑖𝑡   + 𝛽9 𝐷𝑈𝑀𝑀𝑌𝑖𝑡 +  𝑒𝑖  +  𝑢𝑖    (3) 
OOPHE it = 𝛼𝑂𝑂𝑃𝐻𝐸𝑖,𝑡−1 + 𝛽1𝐼𝑁𝐹𝑅𝑖𝑡  + 𝛽2 𝐺𝐷𝑃𝑃𝐶𝑖𝑡  + 𝛽3𝑃𝑂𝑃65𝑖𝑡  +𝛽4 𝑃𝐻𝑀𝐶𝑁𝑖𝑡   
 + 𝛽5 𝑃𝑂𝑃14𝑖𝑡  + 𝛽6 𝑇𝑅𝐸𝐷𝑈𝑖𝑡  +𝛽7 𝑂𝐵𝑆𝑀𝑖𝑡  + 𝛽8 𝐶𝐴𝑁𝐷𝑇𝑖𝑡   +𝛽9 𝐷𝑈𝑀𝑀𝑌𝑖𝑡 +  𝑒𝑖  +  𝑢𝑖    (4) 
 Dummy variable HEFDUM was used to examine whether the relationship differs between 
countries where healthcare is primarily funded by government or otherwise. The mean value of 
government expenditure as a percentage of total health expenditure is 71% [6]. The variable is coded 1 
for countries where more than 71% of healthcare is financed by government and 0 otherwise. The 
dummy variable LANGDUM was used to examine whether new immigrants consume and spend more 
on healthcare in English speaking countries and the variable is coded 1 for English speaking countries 
and 0 for non-English speaking countries. By 2003 only four OECD countries (England, Italy, the 
Netherlands and Sweden) had established dedicated healthcare policies for immigrants [18]. The 
dummy variable IMHPDUM is coded 1 for these four countries and 0 for all other countries to analyse 
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whether new immigrants’ healthcare expenditure differed between countries. The basic hypothesis is 
that having a dedicated healthcare policy for immigrants will encourage them to consume more 
healthcare services.  
2.2 Estimation methodology 
 This study used the ‘Generalized Method of Moments’ (GMM) estimation approach which uses 
the lagged values of the dependent and independent variables in levels and first difference as 
instrumental variables to control for the endogeneity problem in the model. The system GMM estimator 
incorporates the moment conditions at the first difference and in levels for the dynamic panel regression 
model [44]. Many empirical studies have justified the use of the system GMM model because of its 
efficiency in case of small samples and root mean squared error [45, 46]. It is more precise if the models 
suffer from endogeneity, serial correlation, persistence and unobserved heterogeneity [47-49] or if the 
variables have unit root problems [50]. Therefore, the system GMM estimator results are more efficient 
and consistent [51], as well as displaying lower biases [46]. The econometric methodology of system 
GMM is well documented [45, 49, 52] and has been applied in a number of recent studies related to 
healthcare [53, 54]. Therefore, only a brief summary of the approach is presented in this study. The 
following autoregressive model has been considered:   
𝑦𝑖,𝑡 =  𝛼𝑦𝑖,𝑡−1 +  𝛽𝑋𝑖𝑡 +  𝜀𝑖𝑡                   (5) 
 where 𝑦𝑖,𝑡 is the dependent variable (healthcare expenditure), 𝑦𝑖,𝑡−1 is the lagged dependent 
variable and 𝑋𝑖𝑡 represents the vector of all the control variables for country i at time t. 𝜀𝑖𝑡 denotes the  
disturbance term consisting of the fixed effects, e𝑖 , and idiosyncratic errors, u𝑖. Therefore,  
 𝜀𝑖𝑡 =  e𝑖  +  u𝑖           and  
E [e𝑖] = 0, E [u𝑖] = 0, E [e𝑖, u𝑖] = 0 for i = 1,…., N and t = 2,…..,T 
Now, by deducting 𝑦𝑖,𝑡−1 from both side of equation (1) we get, 
𝑑𝑦𝑖,𝑡 = (𝛼−1)𝑦𝑖,𝑡−1 +  𝛽𝑋𝑖𝑡 +  𝜀𝑖𝑡     (6) 
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 The difference GMM estimator takes the first-difference of the data to control unobserved 
country-specific fixed-effects [55] and the system GMM estimator combines the two equations 
simultaneously in first difference and at levels [49]. Therefore, the lagged first-difference of the 
dependent variables and the response variables were used as instruments for the level equations [45]. 
Although, system GMM is an efficient estimator, the accuracy and reliability of the results depends 
upon the appropriate choice of specification tests [56]. To provide evidence of the soundness of the 
estimated outcomes, this study also reports the diagnostic test results including the number of 
instruments in the models, Hansen-J test results, the difference-in-Hansen test results and the test results 
of the second-order serial correlation in the first difference residuals [49, 51].  
 The problem of weak instrument bias or over identification of instruments in the GMM 
approach are common issues. This study used some known measures to account for these matters. For 
all the estimated models with system GMM approach (See Tables 2 and 3) the study reported the Hansen 
J test results. Many studies including those are published recently in the quality journal have used the 
test to validate the instruments used in the GMM method and declared correct GMM model 
specifications (for example Heid, Langer, & Larch, 2012; Hou & Chen, 2013; Nguyen, 2012). 
Secondly, many previous studies have concluded that the Hansen J is a credible ‘post hoc’ test and 
should be checked to ensure the validity of the instruments and moment conditions (Arellano & Bond, 
1988; Kukenova & Monteiro, 2008; Roodman, 2006; Soto, 2007). Thirdly, Bowsher (2002) and 
Roodman (2006) also concluded that too many instruments can overfit the estimated model and this 
will weaken the Hansen J test with an implausibly good p-value of 1.000. The range of the Hansen J 
test results in this study is 0.17 to 0.39. In addition, in all the system GMM tests the number of 
instruments were smaller than N which is suggested by Roodman (2009). Results reported in paragraph 
3 of page 9 in section 3. Fourthly, to ensure the robustness of the estimated results this study conducted 
ordinary least square, fixed effect and panel corrected standard error tests. The resemblance of the 
findings proves the reliability of the GMM approach.  
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3. Results 
 Table 2 shows the results of models 1 and 3 which examines the relationship between public 
healthcare expenditure and the inflow of immigrants. Column A in Table 2 indicates the findings of the 
static panel estimators which are ordinary least square (OLS), fixed-effect (FE) and panel corrected 
standard error (PCSE). Column B shows the system GMM estimator results with lag values for inflow 
of immigrants and column C displays the findings of system GMM estimation results for the models 
with three dummy variables (used separately).   
The estimated results show that inflows of immigrants have no association with growth in 
public healthcare expenditure and the coefficient has the expected sign. Similar to previous studies, 
national income, obesity and improvements in medical technology display a significant relationship 
with rising healthcare expenditure. Interestingly, the under-age population is responsible for growing 
public healthcare expenditure. For every $1000 increase in per capita nominal GDP, the growth rate of 
public healthcare expenditure increases by 0.3-0.4%.  
As expected, in countries where healthcare expenditure is predominantly publicly funded a rise 
in income increases public healthcare expenditure by a greater than proportional amount. A 1% increase 
in the older age population and a 1% increase in the population below 14 increases the growth rate of 
public healthcare expenditure by 1 to 1.7% and 0.9 to 1%, respectively. The coefficients of the variables, 
pharmaceutical consumption and percentage of the population with tertiary education, are negatively 
related to healthcare expenditure although the coefficient values are very small and insignificant. None 
of the dummy variables are significant which means the relationship does not vary significantly between 
countries: i) where healthcare is mostly publicly funded or not; ii) English speaking and non-English 
speaking OECD countries and iii) those who introduced healthcare policy for immigrants or otherwise.  
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Table 2. Determinants of public healthcare expenditure  
  (A)    (B)                                 (C) 
TESTS OLS FE PCSE              System GMM GMM 
Dummy  Variables 
    No lag Lag 1  Lag 2 D1                  D2                D3 
LNPUBHEt-
1 
   0.92*** 
(0.042) 
0.93*** 
(0.042) 
0.91*** 
(0.043) 
0.91*** 
(0.041) 
0.93*** 
(0.04) 
0.92*** 
(0.045) 
INFRit 0.0001* 
(0.000) 
0.0002 
(0.000) 
0.0003 
(0.001) 
0.0006 
(0.000) 
0.0001 
(0.000) 
0.0001* 
(0.000) 
0.0001 
(0.000) 
0.0003 
(0.000) 
0.0001 
(0.000) 
GDPPCit 0.003*** 
(0.001) 
0.001*** 
(0.001) 
0.002*** 
(0.003) 
0.004** 
(0.002) 
0.003* 
(0.002) 
0.004** 
(0.002) 
0.004** 
(0.002) 
0.003* 
(0.002) 
0.003** 
(0.001) 
OBSMit -0.004 
(0.003) 
0.031*** 
(0.006) 
-0.004 
(0.004) 
-0.002 
(0.002) 
-0.003 
(0.002) 
-0.002* 
(0.001) 
-0.002 
(0.002) 
-0.003 
(0.002) 
-0.003 
(0.002) 
POP65it 0.076*** 
(0.006) 
0.034*** 
(0.000) 
0.059*** 
(0.008) 
0.016** 
(0.007) 
0.017** 
(0.007) 
0.01* 
(0.004) 
0.016** 
(0.007) 
0.019** 
(0.008) 
0.017** 
(0.008) 
PHMCNit 0.001*** 
(0.000) 
0.001*** 
(0.000) 
0.001*** 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
0.000 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
TREDUit 0.005*** 
(0.001) 
0.003** 
(0.002) 
0.008*** 
(0.002) 
-0.001 
(0.001) 
-0.001 
(0.001) 
0.000 
(0.000) 
-0.000 
(0.001) 
-0.001 
0.002) 
-0.001 
(0.001) 
POP14it 0.044*** 
(0.005) 
-0.045** 
(0.008) 
0.002*** 
(0.001) 
0.01** 
(0.004) 
0.009** 
(0.004) 
0.01** 
(0.004) 
0.009** 
(0.004) 
0.009** 
(0.004) 
0.009** 
(0.004) 
CANDTit 0.005*** 
(0.000) 
0.001** 
(0.001) 
0.002*** 
(0.001) 
0.001* 
(0.001) 
0.001 
(0.001) 
0.001** 
(0.001) 
0.001** 
(0.000) 
0.001 
(0.001) 
0.001 
(0.001) 
OBS 387 387 387 364 355 343 364 364 364 
Instruments    30 30 30 30 30 30 
Hansen-J    0.17 0.16 0.13 0.144 0.175 0.14 
Diff-in-
Hansen 
   0.655 0.67 0.80 0.58 0.74 0.59 
AR(2)     0.49 0.56 0.48 0.50 0.47 0.49 
R-Sq 0.89 0.90 0.93       
No. of 
Groups 
31 31 31 31 31 31 31 31 31 
Adj R-Sq 0.89         
HEFDUM       0.007 
(0.045) 
  
LANGDUM        0.060 
(0.075) 
 
IMHPDUM         -0.041 
(0.053) 
Notes: Significant at 10, 5, and 1% level is defined by *, **, and ***, respectively. Results based on one step system GMM method with 
robust standard error. Standard error appear in the parentheses. Hansen J-test and the Diff-in-Hansen tests are used to test the null hypothesis 
of validity of the instruments and the validity of the moment restriction in the system GMM approach. AR (2) indicates the Arellano-Bond 
teat for second-order autocorrelation and the null hypothesis is no second-order autocorrelation. The first-order autocorrelation test (not 
reported) always rejected the null hypothesis. The fixed effect estimation also shows the robust standard errors. For PCSE estimation approach 
‘hetonly’ and ‘Corr(ar1)’ options were used. All the estimations were conducted with statistical software ‘STATA’.  
  The static estimation results in column A are consistent with the system GMM results 
for all the models. Only exceptions are pharmaceutical consumptions and tertiary education. According 
to all the static estimator results, both pharmaceutical consumptions and tertiary educated population 
significantly impact on public healthcare expenditure.  
 Table 3 illustrates the findings of models 2 and 4 which investigated the link between out-of-
pocket healthcare expenditure and the inflow of immigrants. Both static and dynamic test results 
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indicate that increasing immigrant populations increases out-of-pocket healthcare expenditure. The 
other two variables that significantly influence out-of-pocket healthcare expenditure are rising per 
capita income and advancements in technology. For every 10,000 additional immigrants the growth rate 
in out-of-pocket healthcare expenditure increases by 0.1 to 0.2%. Interestingly for English speaking 
countries, the impact of the inflow of immigrants are higher (0.3%) on out-of-pocket healthcare 
expenditure compared to other countries. Again, in countries where healthcare expenditure is 
predominantly publicly funded the impact is less (0.13%). Surprisingly, countries who implemented 
dedicated healthcare policies for migrants have an identical coefficient (0.2) to the other countries. 
Similar to the results of model 1, none of the dummy variables are significant although the signs of the 
coefficients are as expected. The static estimation results indicate that tertiary education and 
pharmaceutical consumption significantly increases out-of-pocket healthcare expenditure. The results 
indicate that increase in drug consumption contributes to the out-of-pocket healthcare expenditure by 
0.1%, and a 1% increase in the tertiary educated population increases expenditure by 0.9 to 1%. 
However, the variables are not significant in the GMM estimation results.  
Tables 2 and 3 also report some diagnostic test results. For all of the system GMM estimations 
the number of instruments were between 29 to 30, and the number of groups (N) were 31. The Hansen-
J and difference-in-Hansen test results illustrate the validity of the models and instruments used and the 
AR (2) results specify that the model does not suffer from second-order autocorrelation. 
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Table 3. Determinants of out-of-pocket healthcare expenditure  
 (A) (B) (C) 
TESTS OLS FE PCSE System GMM GMM 
Dummy  Variables 
    No lag Lag 1  Lag 2 D1 D2 D3 
LNOOPHEt-
1 
   0.89*** 
(0.10) 
0.88*** 
(0.097) 
0.92*** 
(0.111) 
0.90*** 
(011) 
0.88*** 
(0.11) 
0.84*** 
(0.14) 
INFRit 0.005*** 
(0.000) 
0.004*** 
(0.001) 
0.0014* 
(0.000) 
0.0013** 
(0.006) 
0.002* 
(0.000) 
0.001* 
(0.000) 
0.0013** 
(0.0006) 
0.003** 
(0.001) 
0.002* 
(0.001) 
GDPPCit 0.009*** 
(0.002) 
0.0003 
(0.0003) 
0.001*** 
(0.002) 
0.003** 
(0.002) 
0.003** 
(0.001) 
0.003* 
(0.002) 
0.004*** 
(0.001) 
0.003 
(0.002) 
0.005 
(0.004) 
OBSMit 0.025*** 
(0.005) 
0.018 
(0.011) 
0.024*** 
(0.005) 
0.004 
(0.003) 
0.003 
(0.003) 
0.003 
(0.002) 
0.003 
(0.002) 
0.005 
(0.004) 
0.007 
(0.005) 
POP65it 0.007 
(0.010) 
0.014 
(0.013) 
0.002 
(0.014) 
-0.002 
(0.010) 
-0.001 
(0.010) 
-0.002 
(0.010) 
-0.002 
(0.002) 
-0.013 
(0.014) 
0.003 
(0.15) 
PHMCNit 0.001*** 
(0.000) 
0.001*** 
(0.000) 
0.001*** 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
-0.000 
(0.000) 
TREDUit 0.009*** 
(0.002) 
0.011*** 
(0.003) 
0.010*** 
(0.002) 
0.003* 
(0.002) 
0.002 
(0.001) 
0.002 
(0.001) 
0.003* 
(0.002) 
0.005* 
(0.003) 
0.003 
(0.002) 
POP14it 0.015* 
(0.008) 
-0.073** 
(0.015) 
0.003 
(0.011) 
0.008 
(0.015) 
0.011 
(0.016) 
0.008 
(0.017) 
0.006 
(0.014) 
0.011 
(0.017) 
0.011 
(0.017) 
CANDTit 0.002*** 
(0.001) 
0.007*** 
(0.001) 
0.002*** 
(0.001) 
0.002** 
(0.001) 
0.001** 
(0.001) 
0.001 
(0.001) 
0.002** 
(0.001) 
0.002** 
(0.001) 
0.002 
(0.001) 
OBS 387 387 387 364 355 343 364 364 364 
Instruments    30 30 29 30 30 30 
Hansen-J    0.36 0.35 0.39 0.30 0.34 0.37 
Diff-in-
Hansen 
   0.54 0.66 0.77 0.44 0.25 0.60 
AR(2) 1st 
Diff 
   0.85 0.91 0.49 0.83 0.96 0.37 
R-Sq 0.70 0.71 0.92       
No. of 
Groups 
31 31 31 31 31 31 31 31 31 
Adj R-Sq 0.69         
HEFDUM       -0.045 
(0.052) 
  
LANGDUM        -0.237 
(0.145) 
 
IMHPDUM         -0.196 
(0.204) 
Notes: Same as Table 2.     
 
4. Discussion 
  The primary findings of the study are that the inflow of new immigrants has no significant 
association with increases in public healthcare expenditure. The results endorses the country specific 
empirical research which concluded that immigrants’ access to healthcare services are limited compared 
to host country populations due to the ‘healthy immigrant effect’ [33, 57]  and the usually rigorous 
health screening process for documented immigrants [58] in OECD countries. Therefore, it is logical to 
find that new immigrants’ impact is insignificant on the consumption of and expenditure on public 
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healthcare. Another key finding is that the rising number of new immigrants has a significant 
relationship with increases in out-of-pocket healthcare expenditure. Both the static and dynamic model 
results illustrated similar results. Hence, this suggests that due to lack of access to the public healthcare 
services, immigrants themselves are paying for their essential healthcare consumption. This reliance on 
out-of-pocket paying for healthcare services may be an important barrier to their use of essential 
healthcare.   
 Similar to previous research, it was found that rising national income and developments in 
medical technologies are the two main drivers of increasing healthcare expenditure. In addition, the 
aging of the population impacts public, but not out-of-pocket, healthcare expenditure significantly. 
Implying that countries generally offer noteworthy public healthcare support for the old age population.  
 Lastly, there is no evidence that new immigrants use publicly funded healthcare services more 
in countries where government healthcare funding is more generous. Moreover, even in countries which 
had dedicated immigrant healthcare policies there was not a significant variation in the results. Hence, 
the general belief that increased immigrant inflows increases overall public healthcare expenditure and 
imposes a burden on the welfare system is not supported. Therefore, this study postulates that having a 
dedicated immigrant healthcare policy will not burden the public budget of the countries. Moreover, 
both financial and nonfinancial barriers to immigrant access to healthcare is need to establish equality 
in healthcare access for all.  
 5. Conclusions 
 The aim of this study was to investigate the impact of the inflow of immigrant populations on 
healthcare expenditure in the OECD countries. The key findings of the study indicate that increasing 
inflows of immigrants has no significant relationship with increasing public healthcare expenditure. 
However, it has a significant association with rising out-of-pocket expenditure. As the number of new 
immigrants increases the level of out-of-pocket healthcare expenditure per person increases, although 
only marginally. The findings also show that growth in national income, medical technological 
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progress, the percentage of the old and young populations are important determinants of rising 
healthcare expenditure.  
 The estimated results of this study support the view that immigrants have unequal access to 
public healthcare and their expenditure on healthcare is less than host country populations. Therefore, 
the findings contradict the prevailing sentiment that immigrants are a burden to the public welfare 
systems as it was found that new immigrants mostly incur out-of-pocket expenditure when consuming 
healthcare services. This clearly explains the lack of consumption of healthcare services by immigrants 
compared to the host country population. The estimated results also promote the idea that only by 
reforming healthcare policy can increases in immigrant use and expenditure on healthcare occur.  
 There are some key policy implications of the findings of this study. First, policymakers should 
realise that providing more generous healthcare policies for new immigrants will not increase public 
expenditure significantly. As past studies have indicated the ‘healthy immigrants’ effect’ and the 
success of the health screening process ensures that new immigrants will not increase their consumption 
of healthcare above that of the host country population. But by offering more generous policies the 
OECD countries could improve healthcare access for immigrants. Second, more research is required to 
identify the nonfinancial barriers to healthcare so that new immigrants can access healthcare. Third, 
greater public awareness should be created regarding the negligible impact of immigrants on publicly 
funded healthcare expenditure in the host countries.  
 In conclusion, although the inflow of immigrants increases the diversity of the population and 
creates new challenges for the healthcare system, this does not trigger a significant rise in public 
expenditure in the OECD countries.  
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